Chimeric alphavirus replicon particles
US9255126B2 · kind B2 · utility
18Cited by
9References
20Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 10, 2009 |
| Grant date | Feb 9, 2016 |
| Priority date | — |
| Expiry date | Aug 4, 2030 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2810/10
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Chimeric alphavirus particles and alphavirus replicon RNAs are provided including methods of making and using same. The alphavirus replicon RNAs comprise deletions in one or more nonstructural proteins. Methods of making, using, and therapeutic preparations containing the chimeric alphavirus particle are disclosed.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.